It has been demonstrated (89) that high expression of CXCL9 in human early stage non-small cell lung cancer, recombinant human cytokine CXCL9 (rhCXCL9), or ligand transfer of CXCL9 can inhibit tumor-derived angiogenesis and suppress the growth and metastasis of tumor cells. Here, CXCL9 is linked to neoplasm.